Search for: "Ely Lilly" Results 1581 - 1600 of 2,157
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Dec 2009, 9:24 pm
Eli Lilly & Co. was heard on Monday before an en banc panel of the Federal Circuit. [read post]
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly – A look back at the… [read post]
7 Dec 2009, 6:00 am by Joe Tort
On December 1, 2009 Judge Weinstein issued a ruling granting partial summary judgment to the pharma company Eli Lilly in the lawsuit by the state of Mississippi concerning Zyprexia. [read post]
6 Dec 2009, 9:55 pm
While most of these companies have taken positions supportive of Lilly on the question of the existence of a separate written description requirement, one company (Novozymes) supports Ariad's position and another... [read post]
4 Dec 2009, 3:01 pm
Panelists for the discussion include Hal Wegner of Foley and Lardner LLP; Larry Welch, the Assistant General Patent Counsel at Eli Lilly and... [read post]
3 Dec 2009, 12:13 am
Federal Judge Knocks Out Most of Mississippi's Zyprexa Case Against Eli Lilly The American Lawyer Mississippi Attorney General Jim Hood's aggressive posture against Eli Lilly in a case involving the controversial anti-psychotic Zyprexa hasn't paid off. [read post]
2 Dec 2009, 5:11 pm
Eli Lilly is about to ponder two questions: (1) is there a separate and distinct “written description” requirement in the first paragraph of 35 U.S.C. [read post]
2 Dec 2009, 6:19 am
"Calling Mississippi Attorney General Jim Hood's lawsuit against Eli Lilly & Co. a 'slash-and-burn style of litigation,' the federal judge overseeing Zyprexa lawsuits has granted Lilly summary judgment. [read post]
1 Dec 2009, 3:53 pm
Die Wettbewerbskommission (WEKO) verhängte laut Medienmitteilung gegen die Pharmaunternehmen Pfizer AG, Eli Lilly (Suisse) SA und Bayer (Schweiz) AG eine Busse von insgesamt CHF 5.7 Mio und verbot ihnen eine weitere Publikation ihrer Preisempfehlungen für drei Hors-Liste-Arzneimittel, weil sie mit Verkaufsstellen unzulässige Preisvereinbarungen getroffen hatten. [read post]
1 Dec 2009, 11:42 am by Beck/Herrmann
This just in - Eli Lilly has received summary judgment against the Mississippi Attorney General's consumer fraud lawsuit in all respects - except one. [read post]
25 Nov 2009, 9:59 pm
Eli Lilly & Co., supporting neither party but arguing in favor of a separate written description requirement as part of 35 U.S.C. [read post]
25 Nov 2009, 12:00 pm
Maharaja Appliances (Spicy IP) India: Harmonising the interpretation of ‘efficacy’ in section 3(d) with Article 27 of TRIPS – IPAB decision in Glivec case (Spicy IP) UK: Medeva pertussis vaccines fail the Art 3 test as question of appeal remains unresolved: Medeva BV’s application (The SPC Blog) US: Amicus briefs in Ariad v Eli Lilly (Patent Docs) (Patent Docs) (Patent Docs) (Patent Docs) US: Senate set to debate merged health care reform bill (FDA Law Blog)… [read post]
24 Nov 2009, 9:59 pm
Eli Lilly & Co., scheduled for December 7th, we have been reviewing a number of the briefs submitted by various amici. [read post]